{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:26:36Z","timestamp":1788967596512,"version":"build-2803163510"},"reference-count":46,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Polish Ministry of Science and Higher Education\u2019s \u201cExcellence Initiative\u2014Research University\u201d","award":["71-01422\/K04-0007229\/61\/256\/256\/2024"],"award-info":[{"award-number":["71-01422\/K04-0007229\/61\/256\/256\/2024"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>4-pyridone-3-carboxamide-1-\u03b2-D-ribonucleoside (4PYR) is a nicotinamide derivative, considered a new oncometabolite. 4PYR formation induced a cytotoxic effect on the endothelium. Elevated blood 4PYR concentration was observed in patients with cancer. Still, little is known about the metabolic and functional effects of 4PYR in this pathology. The study aimed to investigate whether this toxic accumulation of 4PYR may affect the activity of anticancer therapy with cyclophosphamide in the orthotropic model of breast cancer. Female Balb\/c mice were injected with 4T1 breast cancer cells and assigned into three groups: treated with PBS (Control), cyclophosphamide-treated (+CP), 4PYR-treated (+4PYR), and mice treated with both 4PYR and CP(+4PYR+CP) for 28 days. Afterward, blood and serum samples, liver, muscle, spleen, heart, lungs, aortas, and tumor tissue were collected for analysis of concentrations of nucleotides, nicotinamide metabolites, and 4PYR with its metabolites, as well as the liver level of cytochrome P450 enzymes. 4PYR treatment caused elevation of blood 4PYR, its monophosphate and a nicotinamide adenine dinucleotide (NAD+) analog\u20144PYRAD. Blood 4PYRAD concentration in the +4PYR+CP was reduced in comparison to +4PYR. Tumor growth and final tumor mass were significantly decreased in +CP and did not differ in +4PYR in comparison to Control. However, we observed a substantial increase in these parameters in +4PYR+CP as compared to +CP. The extracellular adenosine deamination rate was measured to assess vascular inflammation, and it was higher in +4PYR than the Control. Treatment with 4PYR and CP caused the highest vascular ATP hydrolysis and adenosine deamination rate. 4PYR administration caused significant elevation of CYP2C9 and reduction in CYP3A4 liver concentrations in both +4PYR and +4PYR+CP as compared to Control and +CP. In additional experiments, we compared healthy mice without cancer, treated with 4PYR (4PYR w\/o cancer) and PBS (Control w\/o cancer), where 4PYR treatment caused an increase in the serum proinflammatory cytokine expression as compared to Control w\/o cancer. 4PYR accumulation in the blood interferes with cyclophosphamide anticancer activity and induces a pro-inflammatory shift of endothelial extracellular enzymes, probably by affecting its metabolism by cytochrome P450 enzymes. This observation may have crucial implications for the activity of various anticancer drugs metabolized by cytochrome P450.<\/jats:p>","DOI":"10.3390\/ijms26010035","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T09:00:57Z","timestamp":1735030857000},"page":"35","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["4-Pyridone-3-carboxamide-1-\u03b2-D-ribonucleoside Reduces Cyclophosphamide Effects and Induces Endothelial Inflammation in Murine Breast Cancer Model"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1363-7951","authenticated-orcid":false,"given":"Paulina","family":"Mierzejewska","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, 80-211 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Denslow","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Anticancer Therapy, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 02-103 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Papiernik","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Anticancer Therapy, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 02-103 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Zabrocka","sequence":"additional","affiliation":[{"name":"Regional Center for Blood Donation and Blood Treatment in Gdansk, 80-309 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-9246","authenticated-orcid":false,"given":"Barbara","family":"Kutryb-Zaj\u0105c","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, 80-211 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Charkiewicz","sequence":"additional","affiliation":[{"name":"Department of Perinatology and Obstetrics, Medical University of Bialystok, 15-089 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4394-0292","authenticated-orcid":false,"given":"Alicja","family":"Braczko","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, 80-211 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0190-9414","authenticated-orcid":false,"given":"Ryszard T.","family":"Smole\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, 80-211 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4980-6606","authenticated-orcid":false,"given":"Joanna","family":"Wietrzyk","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Anticancer Therapy, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 02-103 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3037-1844","authenticated-orcid":false,"given":"Ewa M.","family":"S\u0142omi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, 80-211 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"\u0141ukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., and Stanis\u0142awek, A. (2021). Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers, 13.","DOI":"10.3390\/cancers13174287"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent Advances in Therapeutic Strategies for Triple-Negative Breast Cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1124\/pharmrev.120.000121","article-title":"The Nitrogen Mustards","volume":"74","author":"Highley","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and Cancer: Golden Anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jcc.27280","article-title":"Insights on Cyclophosphamide Metabolism and Anticancer Mechanism of Action: A Computational Study","volume":"45","author":"Dabbish","year":"2024","journal-title":"J. Comput. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4862706","DOI":"10.1155\/2024\/4862706","article-title":"Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics","volume":"2024","author":"Steele","year":"2024","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.clbc.2020.09.007","article-title":"Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER+ HER2- Breast Cancer: A Prospective Phase II Study","volume":"20","author":"Hayashi","year":"2020","journal-title":"Clin. Breast Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2156587218757649","DOI":"10.1177\/2156587218757649","article-title":"Protective Effect of Kolaviron on Cyclophosphamide-Induced Cardiac Toxicity in Rats","volume":"23","author":"Omole","year":"2018","journal-title":"J. Evid. Based Integr. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kurauchi, K., Nishikawa, T., Miyahara, E., Okamoto, Y., and Kawano, Y. (2017). Role of Metabolites of Cyclophosphamide in Cardiotoxicity. BMC Res. Notes, 10.","DOI":"10.1186\/s13104-017-2726-2"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"153129","DOI":"10.1016\/j.tox.2022.153129","article-title":"Acrolein Inhalation Acutely Affects the Regulation of Mitochondrial Metabolism in Rat Lung","volume":"469","author":"Tulen","year":"2022","journal-title":"Toxicology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/0024-3205(79)90008-0","article-title":"Isolation and Characterization of 1-Beta-D-Ribofuranosylpyridin-4-One-3-Carboxamide from Human Urine","volume":"24","author":"Dutta","year":"1979","journal-title":"Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"32057","DOI":"10.1074\/jbc.M607514200","article-title":"A Novel Nucleotide Found in Human Erythrocytes, 4-Pyridone-3-carboxamide-1-\u03b2-d-ribonucleoside Triphosphate","volume":"281","author":"Slominska","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/infdis\/174.1.199","article-title":"Pseudouridine and 1-Ribosylpyridin-4-One-3-Carboxamide (PCNR) Serum Concentrations in Human Immunodeficiency Virus Type 1-Infected Patients Are Independent Predictors for AIDS Progression","volume":"174","author":"Intrieri","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/15257770.2019.1600705","article-title":"Increased Plasma Concentration of 4-Pyridone-3-Carboxamide-1-\u00df-D-Ribonucleoside (4PYR) in Lung Cancer. Preliminary Studies","volume":"38","author":"Jablonska","year":"2019","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Jedrzejewska, A., Jablonska, P., Gawlik-Jakubczak, T., Czajkowski, M., Maszka, P., Mierzejewska, P., Smolenski, R.T., and Slominska, E.M. (2024). Elevated Plasma Concentration of 4-Pyridone-3-carboxamide-1-\u03b2-D-ribonucleoside (4PYR) Highlights Malignancy of Renal Cell Carcinoma. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042359"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s12276-021-00669-w","article-title":"An Unusual Nicotinamide Derivative, 4-Pyridone-3-Carboxamide Ribonucleoside (4PYR), Is a Novel Endothelial Toxin and Oncometabolite","volume":"53","author":"Mierzejewska","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1054\/bjoc.2000.1506","article-title":"Intracellular Fas Ligand in Normal and Malignant Breast Epithelium Does Not Induce Apoptosis in Fas-Sensitive Cells","volume":"83","author":"Ragnarsson","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.18632\/aging.205184","article-title":"CCL19: A Novel Prognostic Chemokine Modulates the Tumor Immune Microenvironment and Outcomes of Cancers","volume":"15","author":"Gu","year":"2023","journal-title":"Aging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"104311","DOI":"10.1016\/j.critrevonc.2024.104311","article-title":"The Cytokines in Tumor Microenvironment: From Cancer Initiation-Elongation-Progression to Metastatic Outgrowth","volume":"196","author":"Pradhan","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/cvr\/cvw203","article-title":"Increased Activity of Vascular Adenosine Deaminase in Atherosclerosis and Therapeutic Potential of Its Inhibition","volume":"112","author":"Mateuszuk","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.freeradbiomed.2017.03.038","article-title":"Simultaneous Overexpression of Human E5NT and ENTPD1 Protects Porcine Endothelial Cells against H2O2-Induced Oxidative Stress and Cytotoxicity in Vitro","volume":"108","author":"Chisci","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12964-024-01535-8","article-title":"CD73\/Adenosine Axis Exerts Cardioprotection against Hypobaric Hypoxia-Induced Metabolic Shift and Myocarditis in a Sex-Dependent Manner","volume":"22","author":"Mprah","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1111\/jcmm.13864","article-title":"Adenosine Deaminase Inhibition Suppresses Progression of 4T1 Murine Breast Cancer by Adenosine Receptor-Dependent Mechanisms","volume":"22","author":"Koszalka","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5084713","DOI":"10.1155\/2021\/5084713","article-title":"Nicotinamide Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice through Its Anti-Inflammatory Properties and Modulates the Gut Microbiota","volume":"2021","author":"Kang","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2249.2003.02031.x","article-title":"Nicotinamide Is a Potent Inhibitor of Proinflammatory Cytokines","volume":"131","author":"Ungerstedt","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2017.02.004","article-title":"Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme","volume":"28","author":"Pissios","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1161\/CIRCULATIONAHA.116.026099","article-title":"Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy","volume":"137","author":"Diguet","year":"2018","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1021\/bi972383s","article-title":"Inhibitor and NAD+ Binding to Poly(ADP-Ribose) Polymerase as Derived from Crystal Structures and Homology Modeling","volume":"37","author":"Ruf","year":"1998","journal-title":"Biochemistry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1038\/s41467-024-49983-7","article-title":"Exploring the Structural Landscape of DNA Maintenance Proteins","volume":"15","author":"Schou","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00262-021-03123-y","article-title":"Prognostic Value, DNA Variation and Immunologic Features of a Tertiary Lymphoid Structure-Related Chemokine Signature in Clear Cell Renal Cell Carcinoma","volume":"71","author":"Xu","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.18632\/aging.102233","article-title":"Prognostic Value and Immune Infiltration of Novel Signatures in Clear Cell Renal Cell Carcinoma Microenvironment","volume":"11","author":"Xu","year":"2019","journal-title":"Aging"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00204-021-03204-y","article-title":"Cardiotoxicity of Cyclophosphamide\u2019s Metabolites: An in Vitro Metabolomics Approach in AC16 Human Cardiomyocytes","volume":"96","author":"Bastos","year":"2022","journal-title":"Arch. Toxicol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","article-title":"Comparison of Cytochrome P450 (CYP) Genes from the Mouse and Human Genomes, Including Nomenclature Recommendations for Genes, Pseudogenes and Alternative-Splice Variants","volume":"14","author":"Nelson","year":"2004","journal-title":"Pharmacogenetics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.blre.2017.02.005","article-title":"How Gene Polymorphisms Can Influence Clinical Response and Toxicity Following R-CHOP Therapy in Patients with Diffuse Large B Cell Lymphoma","volume":"31","author":"Falduto","year":"2017","journal-title":"Blood Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1158\/1078-0432.CCR-07-0320","article-title":"The Effect of Repeated Administration of Cyclophosphamide on Cytochrome P450 2B in Rats","volume":"13","author":"Afsharian","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mu\u00f1iz, P., Andr\u00e9s-Zayas, C., Carbonell, D., Chicano, M., Bail\u00e9n, R., Oarbeascoa, G., Su\u00e1rez-Gonz\u00e1lez, J., Centuri\u00f3n, I.G., Dorado, N., and Gallardo, D. (2022). Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1002959"},{"key":"ref_37","first-page":"5629","article-title":"Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes","volume":"53","author":"Chang","year":"1993","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2174\/138920009789895507","article-title":"Structure, Function, Regulation and Polymorphism of Human Cytochrome P450 2A6","volume":"10","author":"Di","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00204-020-02971-4","article-title":"Human Family 1-4 Cytochrome P450 Enzymes Involved in the Metabolic Activation of Xenobiotic and Physiological Chemicals: An Update","volume":"95","author":"Rendic","year":"2021","journal-title":"Arch. Toxicol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/acs.chemrestox.3c00264","article-title":"Synthesis, Detection, and Metabolism of Pyridone Ribosides, Products of NAD Overoxidation","volume":"37","author":"Hayat","year":"2024","journal-title":"Chem. Res. Toxicol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Di Carlo, E., and Sorrentino, C. (2024). Oxidative Stress and Age-Related Tumors. Antioxidants, 13.","DOI":"10.3390\/antiox13091109"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0378-4347(00)82125-8","article-title":"Determination of Sixteen Nucleotides, Nucleosides and Bases Using High-Performance Liquid Chromatography and Its Application to the Study of Purine Metabolism in Hearts for Transplantation","volume":"527","author":"Smolenski","year":"1990","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.bbadis.2017.02.008","article-title":"Deletion of CD73 in Mice Leads to Aortic Valve Dysfunction","volume":"1863","author":"Zukowska","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11010-019-03537-4","article-title":"Impaired l-arginine metabolism marks endothelial dysfunction in CD73-deficient mice","volume":"458","author":"Mierzejewska","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Jablonska, P., Mierzejewska, P., Tomczyk, M., Koszalka, P., Franczak, M., Kawecka, A., Kutryb-Zajac, B., Braczko, A., Smolenski, R.T., and Slominska, E.M. (2022). Differences in Extracellular NAD+ and NMN Metabolism on the Surface of Vascular Endothelial Cells. Biology, 11.","DOI":"10.3390\/biology11050675"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/15257770600894725","article-title":"Liquid Chromatographic\/Mass Spectrometric Procedure for Measurement of NAD Catabolites in Human and Rat Plasma and Urine","volume":"25","author":"Slominska","year":"2006","journal-title":"Nucleosides Nucleotides Nucleic Acids"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/1\/35\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:59:18Z","timestamp":1760115558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/1\/35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["ijms26010035"],"URL":"https:\/\/doi.org\/10.3390\/ijms26010035","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]}}}